ConditionsLower Urinary Tract SymptomsStress Urinary IncontinenceUrge Urinary IncontinenceOveractive BladderPelvic Organ ProlapseWeight LossFecal IncontinenceBariatric Surgeryglp1 Agonist
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18-90
SponsorHartford HealthCare
About this trial
The purpose of this study is to compare change in pelvic floor symptoms between patients receiving medical therapy for weight loss and surgical treatment for weight loss. Examples of pelvic floor symptoms include urinary incontinence, urinary urgency, urinary frequency, fecal incontinence, and vaginal prolapse. Participants in this study do not need to have any pelvic floor symptoms to enroll in the study. Understanding how different types of weight loss treatment impact pelvic floor symptoms will help clinicians guide which weight loss treatments are recommended for patients with pelvic floor symptoms in the future.
Eligibility criteria
Qualifiers
female
18-89 years old
any race/ethnicity
BMI ≥30 kg/m2
Disqualifiers
Pregnant
≥90 years old
<18 years old
BMI <30 kg/m2
Trial design
Treatments tested in this trial
- Bariatric Surgery
- GLP1 receptor agonist
Treatment groups
200 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov